Literature DB >> 18539904

A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization.

Manolis Mavroidis1, Panagiota Panagopoulou, Ioanna Kostavasili, Noah Weisleder, Yassemi Capetanaki.   

Abstract

A missense mutation (Ile 451 to Met) at the tail domain of the muscle-specific intermediate filament protein desmin has been suggested to be a genetic cause of dilated cardiomyopathy. The Ile451Met mutation is located inside a conserved motif in the desmin tail domain, believed to have a potential role in the lateral packing of type III intermediate filaments. Nevertheless, the role of the type III intermediate filament tail domain remains elusive. To further study the role of this domain in the function of cardiomyocytes and in the development of cardiomyopathy, we generated transgenic mice expressing the mutant desmin(I451M) in the cardiac tissue. Analysis of hearts from transgenic animals revealed that mutant desmin loses its Z-disc localization but it can still associate with the intercalated discs, which, however, have an altered architecture, resembling other examples of dilated cardiomyopathy. This is the first report demonstrating a critical role of the desmin head and tail domains in the formation of the IF scaffold around Z discs. It is further suggested that in cardiomyocytes, an interplay between desmin tail and head domains is taking place, which potentially protects the amino terminus of desmin from specific proteases. The fact that the association with intercalated discs seems unchanged suggests that this association must take place through the desmin tail, in contrast to the head domain that is most possibly involved in the Z-disc binding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539904      PMCID: PMC2638966          DOI: 10.1096/fj.07-088724

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  49 in total

Review 1.  Intermediate filaments: molecular architecture, assembly, dynamics and polymorphism.

Authors:  D A Parry; P M Steinert
Journal:  Q Rev Biophys       Date:  1999-05       Impact factor: 5.318

2.  Acute effects of desmin mutations on cytoskeletal and cellular integrity in cardiac myocytes.

Authors:  Kurt Haubold; Harald Herrmann; Stephen J Langer; Robert M Evans; Leslie A Leinwand; Michael W Klymkowsky
Journal:  Cell Motil Cytoskeleton       Date:  2003-02

3.  The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function.

Authors:  D J Milner; G E Taffet; X Wang; T Pham; T Tamura; C Hartley; A M Gerdes; Y Capetanaki
Journal:  J Mol Cell Cardiol       Date:  1999-11       Impact factor: 5.000

4.  Null mutation in the desmin gene gives rise to a cardiomyopathy.

Authors:  L Thornell; L Carlsson; Z Li; M Mericskay; D Paulin
Journal:  J Mol Cell Cardiol       Date:  1997-08       Impact factor: 5.000

5.  Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy.

Authors:  Manolis Mavroidis; Yassemi Capetanaki
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

6.  Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations.

Authors:  Marinos C Dalakas; Ayush Dagvadorj; Bertrand Goudeau; Kye-Yoon Park; Kazuyo Takeda; Monique Simon-Casteras; Olavo Vasconcelos; Nyamkhishig Sambuughin; Alexey Shatunov; James W Nagle; Kumaraswamy Sivakumar; Patrick Vicart; Lev G Goldfarb
Journal:  Neuromuscul Disord       Date:  2003-03       Impact factor: 4.296

7.  Amino-terminally truncated desmin rescues fusion of des(-/-) myoblasts but negatively affects cardiomyogenesis and smooth muscle development.

Authors:  Alexandra Höllrigl; Sonja Puz; Haifa Al-Dubai; Jai Up Kim; Yassemi Capetanaki; Georg Weitzer
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

Review 8.  Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function.

Authors:  Yassemi Capetanaki
Journal:  Trends Cardiovasc Med       Date:  2002-11       Impact factor: 6.677

Review 9.  Dilated cardiomyopathy: a disease of the intercalated disc?

Authors:  Jean-Claude Perriard; Alain Hirschy; Elisabeth Ehler
Journal:  Trends Cardiovasc Med       Date:  2003-01       Impact factor: 6.677

10.  Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function.

Authors:  D J Milner; M Mavroidis; N Weisleder; Y Capetanaki
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

View more
  15 in total

Review 1.  Desmin related disease: a matter of cell survival failure.

Authors:  Yassemi Capetanaki; Stamatis Papathanasiou; Antigoni Diokmetzidou; Giannis Vatsellas; Mary Tsikitis
Journal:  Curr Opin Cell Biol       Date:  2015-02-11       Impact factor: 8.382

Review 2.  Intermediate filaments in cardiomyopathy.

Authors:  Mary Tsikitis; Zoi Galata; Manolis Mavroidis; Stelios Psarras; Yassemi Capetanaki
Journal:  Biophys Rev       Date:  2018-07-19

3.  What does desmin do: A bibliometric assessment of the functions of the muscle intermediate filament.

Authors:  Geyse Gomes; Marianna R Seixas; Sarah Azevedo; Karina Audi; Arnon D Jurberg; Claudia Mermelstein; Manoel Luis Costa
Journal:  Exp Biol Med (Maywood)       Date:  2022-02-07

Review 4.  Desminopathies: pathology and mechanisms.

Authors:  Christoph S Clemen; Harald Herrmann; Sergei V Strelkov; Rolf Schröder
Journal:  Acta Neuropathol       Date:  2012-11-11       Impact factor: 17.088

5.  αB-crystallin is a sensor for assembly intermediates and for the subunit topology of desmin intermediate filaments.

Authors:  Sarika Sharma; Gloria M Conover; Jayne L Elliott; Ming Der Perng; Harald Herrmann; Roy A Quinlan
Journal:  Cell Stress Chaperones       Date:  2017-05-03       Impact factor: 3.667

Review 6.  Myofibrillar Myopathies: New Perspectives from Animal Models to Potential Therapeutic Approaches.

Authors:  Sabrina Batonnet-Pichon; Anthony Behin; Eva Cabet; Florence Delort; Patrick Vicart; Alain Lilienbaum
Journal:  J Neuromuscul Dis       Date:  2017

7.  Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model.

Authors:  Beatriz Llamusi; Ariadna Bargiela; Juan M Fernandez-Costa; Amparo Garcia-Lopez; Raffaella Klima; Fabian Feiguin; Ruben Artero
Journal:  Dis Model Mech       Date:  2012-11-01       Impact factor: 5.758

8.  Viral-mediated expression of desmin mutants to create mouse models of myofibrillar myopathy.

Authors:  Julie Dumonceaux; Onnik Agbulut; Pierre Joanne; Oussama Chourbagi; Christophe Hourdé; Arnaud Ferry; Gillian Butler-Browne; Patrick Vicart
Journal:  Skelet Muscle       Date:  2013-02-20       Impact factor: 4.912

9.  N-acetyl-L-cysteine prevents stress-induced desmin aggregation in cellular models of desminopathy.

Authors:  Bertrand-David Segard; Florence Delort; Virginie Bailleux; Stéphanie Simon; Emilie Leccia; Blandine Gausseres; Fatma Briki; Patrick Vicart; Sabrina Batonnet-Pichon
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

10.  Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation.

Authors:  Mei-Hsuan Chen; Tracy L Hagemann; Roy A Quinlan; Albee Messing; Ming-Der Perng
Journal:  ASN Neuro       Date:  2013-11-19       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.